433 related articles for article (PubMed ID: 24932742)
1. A rationale to target the SWI/SNF complex for cancer therapy.
Hohmann AF; Vakoc CR
Trends Genet; 2014 Aug; 30(8):356-63. PubMed ID: 24932742
[TBL] [Abstract][Full Text] [Related]
2. Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy.
Wanior M; Krämer A; Knapp S; Joerger AC
Oncogene; 2021 May; 40(21):3637-3654. PubMed ID: 33941852
[TBL] [Abstract][Full Text] [Related]
3. Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.
Wang X; Sansam CG; Thom CS; Metzger D; Evans JA; Nguyen PT; Roberts CW
Cancer Res; 2009 Oct; 69(20):8094-101. PubMed ID: 19789351
[TBL] [Abstract][Full Text] [Related]
4. Novel Interactions between the Human T-Cell Leukemia Virus Type 1 Antisense Protein HBZ and the SWI/SNF Chromatin Remodeling Family: Implications for Viral Life Cycle.
Alasiri A; Abboud Guerr J; Hall WW; Sheehy N
J Virol; 2019 Aug; 93(16):. PubMed ID: 31142665
[TBL] [Abstract][Full Text] [Related]
5. BAFfling pathologies: Alterations of BAF complexes in cancer.
Arnaud O; Le Loarer F; Tirode F
Cancer Lett; 2018 Apr; 419():266-279. PubMed ID: 29374542
[TBL] [Abstract][Full Text] [Related]
6. A New Way Forward in Cancer Drug Discovery: Inhibiting the SWI/SNF Chromatin Remodelling Complex.
Zinzalla G
Chembiochem; 2016 Apr; 17(8):677-82. PubMed ID: 26684344
[TBL] [Abstract][Full Text] [Related]
7. BAF60A mediates interactions between the microphthalmia-associated transcription factor and the BRG1-containing SWI/SNF complex during melanocyte differentiation.
Aras S; Saladi SV; Basuroy T; Marathe HG; Lorès P; de la Serna IL
J Cell Physiol; 2019 Jul; 234(7):11780-11791. PubMed ID: 30515787
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer--mechanisms and potential therapeutic insights.
Wang X; Haswell JR; Roberts CW
Clin Cancer Res; 2014 Jan; 20(1):21-7. PubMed ID: 24122795
[TBL] [Abstract][Full Text] [Related]
9. Mammalian SWI/SNF complexes in cancer: emerging therapeutic opportunities.
St Pierre R; Kadoch C
Curr Opin Genet Dev; 2017 Feb; 42():56-67. PubMed ID: 28391084
[TBL] [Abstract][Full Text] [Related]
10. BRM: the core ATPase subunit of SWI/SNF chromatin-remodelling complex-a tumour suppressor or tumour-promoting factor?
Jancewicz I; Siedlecki JA; Sarnowski TJ; Sarnowska E
Epigenetics Chromatin; 2019 Nov; 12(1):68. PubMed ID: 31722744
[TBL] [Abstract][Full Text] [Related]
11. Cdx2 Regulates Gene Expression through Recruitment of Brg1-associated Switch-Sucrose Non-fermentable (SWI-SNF) Chromatin Remodeling Activity.
Nguyen TT; Savory JGA; Brooke-Bisschop T; Ringuette R; Foley T; Hess BL; Mulatz KJ; Trinkle-Mulcahy L; Lohnes D
J Biol Chem; 2017 Feb; 292(8):3389-3399. PubMed ID: 28082674
[TBL] [Abstract][Full Text] [Related]
12. SWI/SNF chromatin remodeling and human malignancies.
Masliah-Planchon J; Bièche I; Guinebretière JM; Bourdeaut F; Delattre O
Annu Rev Pathol; 2015; 10():145-71. PubMed ID: 25387058
[TBL] [Abstract][Full Text] [Related]
13. Functional selectivity of recombinant mammalian SWI/SNF subunits.
Kadam S; McAlpine GS; Phelan ML; Kingston RE; Jones KA; Emerson BM
Genes Dev; 2000 Oct; 14(19):2441-51. PubMed ID: 11018012
[TBL] [Abstract][Full Text] [Related]
14. The spectrum of SWI/SNF mutations, ubiquitous in human cancers.
Shain AH; Pollack JR
PLoS One; 2013; 8(1):e55119. PubMed ID: 23355908
[TBL] [Abstract][Full Text] [Related]
15. The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies.
Vangamudi B; Paul TA; Shah PK; Kost-Alimova M; Nottebaum L; Shi X; Zhan Y; Leo E; Mahadeshwar HS; Protopopov A; Futreal A; Tieu TN; Peoples M; Heffernan TP; Marszalek JR; Toniatti C; Petrocchi A; Verhelle D; Owen DR; Draetta G; Jones P; Palmer WS; Sharma S; Andersen JN
Cancer Res; 2015 Sep; 75(18):3865-3878. PubMed ID: 26139243
[TBL] [Abstract][Full Text] [Related]
16. In silico screening of cancer-associated mutations in the HSA domain of BRG1 and its role in affecting the Arp-HSA sub-complex of SWI/SNF.
S AS; Goutham R N A; Mohan S S
Comput Biol Chem; 2018 Dec; 77():109-115. PubMed ID: 30286321
[TBL] [Abstract][Full Text] [Related]
17. SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities.
Andrades A; Peinado P; Alvarez-Perez JC; Sanjuan-Hidalgo J; García DJ; Arenas AM; Matia-González AM; Medina PP
Mol Cancer; 2023 Feb; 22(1):39. PubMed ID: 36810086
[TBL] [Abstract][Full Text] [Related]
18. Loss of Snf5 Induces Formation of an Aberrant SWI/SNF Complex.
Sen P; Luo J; Hada A; Hailu SG; Dechassa ML; Persinger J; Brahma S; Paul S; Ranish J; Bartholomew B
Cell Rep; 2017 Feb; 18(9):2135-2147. PubMed ID: 28249160
[TBL] [Abstract][Full Text] [Related]
19. Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities.
Orlando KA; Nguyen V; Raab JR; Walhart T; Weissman BE
Expert Rev Anticancer Ther; 2019 May; 19(5):375-391. PubMed ID: 30986130
[TBL] [Abstract][Full Text] [Related]
20. The role of the SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma.
Tsuda M; Fukuda A; Kawai M; Araki O; Seno H
Cancer Sci; 2021 Feb; 112(2):490-497. PubMed ID: 33301642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
